New Zealand markets close in 4 hours 49 minutes

LLY Jan 2024 170.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
360.900.00 (0.00%)
As of 02:46PM EDT. Market open.
Full screen
Previous close360.90
Expiry date2024-01-19
Day's range360.50 - 361.00
Contract rangeN/A
Open interest26
  • Zacks

    Lilly (LLY) to Buy POINT Biopharma, Strengthen Cancer Portfolio

    Eli Lilly's (LLY) acquisition of POINT Biopharma, if successfully closed, is likely to bolster its portfolio of cancer drugs.

  • Motley Fool

    Why Eli Lilly Stock Was Looking Sickly Today

    After announcing that it signed a deal to acquire Point Biopharma Global (NASDAQ: PNT), its share price headed south to end the day 2.4% lower. Before market open, Eli Lilly divulged that it has agreed to acquire Point for a total of roughly $1.4 billion in cash, or $12.50 per share. The latter is nearly double Point's closing share price on Monday.

  • Yahoo Finance Video

    Cruise lines, spinoff slumps, Eli Lilly-Point deal: Trending Stocks

    Shares of cruise line stocks Carnival Corp. (CCL), Royal Caribbean (RCL), and Norwegian (NCLH) close lower on Tuesday as Morgan Stanley analysts slash their price targets, citing rising fuel costs in travel demand headwinds. Recently spun-off companies Vestis Corporation (VSTS), Veralto (VLTO), and WK Kellogg Co. (KLG) slide lower following their listing debuts. Lastly, pharmaceutical giant Eli Lilly (LLY) is set to acquire Point Biopharma (PNT) in a $1.4 billion deal. Yahoo Finance Live takes a closer look at several of Tuesday's trending stocks after the closing bell from the New York Stock Exchange. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.